Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,070,239
+$7,610,296 QoQ
Shares Held
591,675
+70.2% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 256 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Derivatives in RLAY
reported options exposure · as of Mar 31, 2023CallValue
$3,129,300
CallShares
190,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. RLAY ranks #100 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,070,239 | 591,675 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,459,943 | 347,733 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,587,850 | 896,909 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,883,909 | 744,044 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,471,452 | 1,870,362 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,710,332 | 2,942,875 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,581,742 | 2,568,384 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,502,017 | 1,059,607 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,492,634 | 1,149,177 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,891,619 | 227,906 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,058,495 | 186,966 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,058,445 | 958,198 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,771,411 | 1,574,157 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,129,300 | 190,000 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $809,748 | 54,200 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $8,592,531 | 575,136 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $900,034 | 40,234 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,108,079 | 185,557 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $411,836 | 13,760 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $645,923 | 21,033 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $315,300 | 10,000 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $559,909 | 17,758 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $793,658 | 22,958 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,896,524 | 69,695 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||